Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-184685
Filing Date
2012-04-26
Accepted
2012-04-26 11:47:54
Documents
3
Period of Report
2012-05-31
Effectiveness Date
2012-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d338649ddef14a.htm DEF 14A 514243
2 GRAPHIC g338649g22d38.jpg GRAPHIC 158420
3 GRAPHIC g338649g67u96.jpg GRAPHIC 147696
  Complete submission text file 0001193125-12-184685.txt   937432
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 033-80623 | Film No.: 12782231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances